NEPHROS, INC. Finite-lived Intangible Assets Acquired
NEPHROS, INC. (NEPH) reported Finite-lived Intangible Assets Acquired of $590.00 thousand for the 12-month period ending 2019-12-31, per its 10-K filed 2020-02-27.
Discontinued › Notes › Goodwill and Other
us-gaap:FinitelivedIntangibleAssetsAcquired1 · last filed 2020-02-27
- NEPHROS, INC. finite-lived intangible assets acquired for the quarter ending 2019-12-31 was $0.00.
- NEPHROS, INC. finite-lived intangible assets acquired for the quarter ending 2019-09-30 was $0.00.
- NEPHROS, INC. finite-lived intangible assets acquired for the quarter ending 2019-06-30 was $0.00.
- NEPHROS, INC. finite-lived intangible assets acquired for the quarter ending 2019-03-31 was $590.00K.
- NEPHROS, INC. finite-lived intangible assets acquired for fiscal 2019 was $590.00K, a 0.00% change from fiscal 2018.
- NEPHROS, INC. finite-lived intangible assets acquired for fiscal 2018 was $590.00K.
| Period end | Finite-lived Intangible Assets Acquired 3 month | Finite-lived Intangible Assets Acquired 6 month | Finite-lived Intangible Assets Acquired 9 month | Finite-lived Intangible Assets Acquired 12 month |
|---|---|---|---|---|
| 2019-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2020-02-27 | $0.00 derived: sum of 2 quarters · filed 2020-02-27 | $0.00 derived: sum of 3 quarters · filed 2020-02-27 | $590.00K 10-K · filed 2020-02-27 |
| 2019-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2019-11-06 | $0.00 derived: sum of 2 quarters · filed 2019-11-06 | $590.00K 10-Q · filed 2019-11-06 | |
| 2019-06-30 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2019-08-07 | $590.00K 10-Q · filed 2019-08-07 | ||
| 2019-03-31 | $590.00K 10-Q · filed 2019-05-08 | |||
| 2018-12-31 | $590.00K 10-K · filed 2019-03-12 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Sensus Healthcare, Inc. (SRTS) | United States | $0.048B | -3.24 |
| SANUWAVE Health, Inc. (SNWV) | United States | $0.041B | 5.47 |
| Spectral AI, Inc. (MDAI) | United States | $0.052B | |
| Xtant Medical Holdings, Inc. (XTNT) | United States | $0.053B | |
| TELA Bio, Inc. (TELA) | United States | $0.057B | -0.82 |
| InspireMD, Inc. (NSPR) | $0.033B | ||
| PAVmed Inc. (PAVM) | United States | $0.031B | -3.00 |
| Glucotrack, Inc. (GCTK) | United States | $0.027B | |
| ACCURAY INC (ARAY) | United States | $0.027B | -0.63 |
| DarioHealth Corp. (DRIO) | $0.066B | -1.39 |